SciClone begins Phase III Zadaxin trials

SCLN began two U.S. Phase III trials of Zadaxin in combination with Roche's Pegasys pegylated interferon alpha-2a. The two double-blind trials each will enroll 500 patients with hepatitis C virus who ...